Infographic: TB Vaccines in the Pipeline Take Varied Approaches
Infographic: TB Vaccines in the Pipeline Take Varied Approaches
More than a dozen vaccines for tuberculosis are currently being tested in clinical trials. Some use whole bacteria as BCG does, while others deliver protein subunits or genetic material carried by viral vectors.  
Infographic: TB Vaccines in the Pipeline Take Varied Approaches
Infographic: TB Vaccines in the Pipeline Take Varied Approaches

More than a dozen vaccines for tuberculosis are currently being tested in clinical trials. Some use whole bacteria as BCG does, while others deliver protein subunits or genetic material carried by viral vectors.  

More than a dozen vaccines for tuberculosis are currently being tested in clinical trials. Some use whole bacteria as BCG does, while others deliver protein subunits or genetic material carried by viral vectors.  

T cell
Tuberculosis: The Forgotten Pandemic
Tuberculosis: The Forgotten Pandemic
Anthony King | Jul 1, 2021
This month marks the 100-year anniversary of BCG, still the only approved vaccine against the lethal pathogen. But there are new vaccines for this wily foe on the horizon.
Microbes in Human Fetuses Spur Immune Development
Microbes in Human Fetuses Spur Immune Development
Abby Olena | Jun 3, 2021
Researchers identify live bacteria in fetal guts, skin, lungs, and placentas that activate memory T cells, indicating that early exposure to microbes could help educate the developing immune system.
Mucosal Vaccines Protect Mice from Viruses, Cancer
Mucosal Vaccines Protect Mice from Viruses, Cancer
Emma Yasinski | Jun 1, 2021
Scientists use a protein found in mucus membranes to ferry vaccines to the lymph nodes.
Ohio State Researcher Sentenced to Prison for Secret China Ties
Ohio State Researcher Sentenced to Prison for Secret China Ties
Lisa Winter | May 17, 2021
Rheumatologist Song Guo Zheng pleaded guilty in November to delivering US-funded research to China.
COVID-19 More Deadly with Blood than Solid Cancer: Study
COVID-19 More Deadly with Blood than Solid Cancer: Study
Marcus A. Banks | Feb 16, 2021
Death rates among blood cancer patients who contract COVID-19 are higher than for those with other cancers, pointing to impaired immunity that makes it hard to overcome the virus.
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Anthony King | Nov 11, 2020
Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 
Doctors Consider Convalescent T Cell Therapy for COVID-19
Doctors Consider Convalescent T Cell Therapy for COVID-19
Abby Olena | Nov 6, 2020
Researchers propose that an infusion of memory T cells from people who have recovered from SARS-CoV-2 infections could treat severe disease.
Baking Soda Boosts T Cells’ Ability to Fight Leukemia
Baking Soda Boosts T Cells’ Ability to Fight Leukemia
Rachael Moeller Gorman | Nov 2, 2020
Infusions of donor T cells to fight the cancer often fail, but sodium bicarbonate can counter lactic acid produced by leukemia cells, potentially improving remission rates in mice and humans.
T Cells and Neurons Talk to Each Other
T Cells and Neurons Talk to Each Other
Ashley Yeager | Oct 1, 2020
Conversations between the immune and central nervous systems are proving to be essential for the healthy social behavior, learning, and memory.
Infographic: How Cytokines Flow into and out of the Brain
Infographic: How Cytokines Flow into and out of the Brain
Ashley Yeager | Oct 1, 2020
Several routes exist for immune cells to communicate with neurons in the central nervous system, though T cells rarely come in direct contact with neural tissue.
Kids’ Severe COVID-19 Reaction Bears Unique Immune Signature
Kids’ Severe COVID-19 Reaction Bears Unique Immune Signature
Shawna Williams | Sep 29, 2020
The rare complication known as multisystem inflammatory syndrome in children (MIS-C) differs from both Kawasaki disease and severe adult cases of COVID-19, a study finds.
Some COVID-19 Patients Lack Key Structures for Antibody Creation
Some COVID-19 Patients Lack Key Structures for Antibody Creation
Katarina Zimmer | Aug 25, 2020
An absence of germinal centers—which arise during infections to produce long-lived antibody-generating cells—might explain rapidly waning antibody levels in the disease.
Does the Common Cold Protect You from COVID-19?
Does the Common Cold Protect You from COVID-19?
Chris Baraniuk | Aug 4, 2020
There are emerging signs that some people might have heightened protection against SARS-CoV-2, perhaps thanks to recent infection by other coronaviruses.